bladder urachal carcinoma
bladder urachal carcinoma
Explore linked clinical trials. Standard reference: MONDO:00037155 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Agnostic Therapy in Rare Solid Tumors | Adnexal Diseases, Biliary Tract Neoplasms, Carcinoma, Ovarian Epithelial, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, MIT family translocation renal cell carcinoma, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Parathyroid Neoplasms, Pregnancy Complications, Neoplastic, Sertoli-Leydig cell tumor, Sex Cord-Gonadal Stromal Tumors, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adenoid cystic carcinoma, adenoma, adrenal gland cancer, adrenal gland disorder, angiosarcoma, anus disorder, anus neoplasm, apocrine adenocarcinoma, benign urinary system neoplasm, biliary tract disorder, bladder urachal adenocarcinoma, bladder urachal carcinoma, breast secretory carcinoma, capillary hemangioma, carcinoma, carcinosarcoma, cholangiocarcinoma, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, fibrolamellar hepatocellular carcinoma, fibrosarcoma, gallbladder disorder, gallbladder neoplasm, gonadal disorder, gonadal tissue neoplasm, granulosa cell tumor, hemangioblastoma, hemangioma, hepatoblastoma, intestinal disorder, leiomyosarcoma, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, mesonephric neoplasm, mesothelial neoplasm, mesothelioma, metaplastic breast carcinoma, mixed neoplasm, myomatous neoplasm, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroblastoma, neuroendocrine neoplasm, neuroepithelial neoplasm, neurofibroma, neurofibrosarcoma, neuromuscular disease, osteosarcoma, ovarian cancer, ovarian disorder, parathyroid gland carcinoma, parathyroid gland disorder, penile disorder, penile neoplasm, peripheral nervous system disorder, peripheral nervous system neoplasm, pregnancy disorder, primitive neuroectodermal tumor, rectal disorder, rectal neoplasm, sarcoma, testicular cancer, testicular disorder, thyroid gland disorder, thyroid tumor, trophoblastic neoplasm, urethra neoplasm, urethral disorder, urinary system disorder, vaginal cancer, vaginal disorder, vascular cancer, viral infectious disease, vulva cancer, vulvar disease, yolk sac tumor | Recruiting | Phase 2 | 2026-04-15 | NCT06638931 | |
| Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies | Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, bladder urachal carcinoma, carcinoma, epithelial neoplasm, extramammary Paget disease, neoplasm | Recruiting | Phase 2 | 2025-12-30 | NCT07309770 | |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, bladder urachal carcinoma, neoplasm, urethra neoplasm, urethral disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2025-09-09 | NCT00082706 | |
| Ivonescimab in the Treatment of Multiple Advanced Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, angiomyolipoma, basal cell carcinoma, basal cell neoplasm, benign urinary system neoplasm, bladder urachal carcinoma, carcinoma, epithelial neoplasm, extramammary Paget disease, kidney angiomyolipoma, kidney cancer, kidney disorder, male reproductive organ cancer, male reproductive system disorder, myomatous neoplasm, neoplasm, neoplasm with perivascular epithelioid cell differentiation, neuroendocrine carcinoma, neuroendocrine neoplasm, paraganglioma, penile cancer, penile disorder, penile neoplasm, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rhabdomyosarcoma, sarcoma, sarcomatoid carcinoma, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Recruiting | Phase 2 | 2025-08-24 | NCT06683846 | |
| Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors | Genital Diseases, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, bladder urachal carcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, extramammary Paget disease, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, myomatous neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm, rhabdomyosarcoma, sarcoma, testicular cancer, testicular disorder | Recruiting | Phase 2 | 2024-12-20 | NCT06684327 |